Vincent PRÊTET

Entrepreneur turned VC Investor Industrializing Deeptech Ventures

📍 France🔄 Updated September 2026💼 40 investments📅 5 years investing🗓 Last invested Oct 2024
VC🌍 France20+ investments
40
Total investments
3
Early stage
12
Mid stage
12
Late stage
5y
Years active

Portfolio

32 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Apr 2024
Nova Carbons mission is to democratize the use of carbon fiber by developing a range of high performance semi-finished products made from carbon fiber waste. Nova Carbons disruptive approach is based on Long Fiber Realignment, a technology patented by the University of Bordeaux that maintains the high performance of carbon fiber. Our semi-finished products are designed for the composites industry.
Board Member
Nov 2023
RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated.
early stageMedical Device
Board Member
Nov 2023
SOTIMECO was born in 2017, from a meeting of minds eager to combine innovation with utility. Since then, our team has continued to grow, as have our ideas. Our main mission? To transform the metal additive manufacturing industry by making innovation not only accessible but also beneficial for everyone.
VC Investor
Nov 2023
Discover the best certified 2 seater light aircraft available. Training, travel or leisure, the future of general aviation is here.
VC Investor
Nov 2023
Dyameo est une société de recherche & développement dans le domaine des dispositifs médicaux qui conçoit des sondes daide au diagnostic de cellules cancéreuses in-vivo. Ce dispositif médical, permet de répondre à la question: "Ces cellules sont-elle cancéreuses?", et cela de manière simple, claire et instantanée. Cette solution de rupture propose de discriminer les cellules cancéreuses à un stade précoce, lors dexamens endoscopiques.
VC Investor
Oct 2023
Le dispositif médical HUVY s’appuie sur l’intelligence artificielle pour évaluer le risque de mélanome d’une lésion pigmentée. Déployé à grande échelle, HUVY aide les professionnels de santé à détecter facilement et rapidement les melanomes afin d’orienter les cas suspects vers les dermatologues. HUVY est la première solution de sa catégorie à obtenir un marquage CE IIB en Europe (MDR 2017/745).
VC Investor
Oct 2023
Bus stops. Traffic jams. Empty docks. Life’s too short... and you were made to move. Which is why the moment has come for a movement. To unchain the city and give you free rein: whoever you are and wherever you’re going. A movement powered by Pony. No docking. No hassle. No limits. Not just getting around. Changing the way the world goes round.
Board Member
Oct 2023
Cyclair développe des produits technologiques qui permettent une réduction spectaculaire des volumes d’intrants chimiques, tout en continuant de protéger les cultures et assurer les rendements actuels, voire les améliorer. Nous travaillons aussi nos offres de manière à les rendre acceptable d’un point de vue économique.
mid stageFarming
VC Investor
Jul 2023
ELICIT PLANT is an AGtech company and a pioneer in the stimulation of field-grown plants through the use of phytosterols. By reducing plant water stress, our patented technology increases yield in situation of lack of water. Elicit Plant develops and provides new effective prevention products against the stress suffered by plants grown by the intake of exogenous phytosterols in the field. Elicit Plant offers a novel solution for reducing water consumption for the cultivation of targeted plants and helps to fight against water stress. Elicit Plants develops a methodology to collect soil, plant development and climate data to quantify the results obtained under real-life conditions.
VC Investor
Jul 2023
Somno Engineering develop a solution for improv sleep quality in ICU patients.
early stageMedical Device
VC Investor
Jul 2023
TreeFrog Therapeutics is a French-based biotech company aiming to unlock access to cell therapies for millions of patients. TreeFrog Therapeutics is developing a pipeline of therapeutic candidates using proprietary C-Stem technology, allowing for the mass production of induced pluripotent stem cells and their differentiation into ready-to-transplant microtissues with unprecedented scalability and cell quality. Bringing together over 150 biophysicists, cell biologists and bioproduction engineers, TreeFrog Therapeutics raised $82M in 2021 to advance its pipeline of stem cell-based therapies in the field of regenerative medicine with the lead program in Parkinsons Disease. In 2022, the company opened a technological hub in Boston, USA to drive the adoption of C-Stem and initiate co-development partnerships with leading academic, biotech and industry players in the field of cell therapy.
VC Investor
Jul 2023
At DESKi, we focus on creating a smarter path to heart exams for all, actively taking on the world’s #1 killer, Heart Disease. By leveraging the skills of our audacious and committed team, we created HeartFocus in 2023, a ground-breaking AI-powered software, designed to let any healthcare professional perform heart exams with precision, anywhere. Based in Bordeaux, France, our team is international, committed and believe No heart can wait ™
VC Investor
Jul 2023
Inspeere est une société proposant la seule solution de sauvegarde informatique distibuée pour les entreprises et organisations à tarif unique quel que soit la quantité de données. La solution dInspeere repose sur de nombreuses années de recherche au sein du Laboratoire I3S, UMR CNRS.
VC Investor
Jul 2023
Certis Therapeutics develops and markets minimally invasive thermo-ablation solutions. These solutions are controlled by real time MRI images including accurate 3D temperature maps and deliver treatments for cardiological, oncological and neurological diseases. The company aims at providing best in class solutions delivering significantly higher efficacy and safety as to current standards of care.
VC Investor
Jul 2023
Sensity Tech®, the technology that makes materials (solid or flexible) sensitive to physical interactions : - The material surface becomes a sensitive and connected surface - Data recover from pressure, extension, deformation and damage - Modeling and location in real time as a 2D or 3D mapping - Interaction intensity characterisation suffered by the material - Using artificial intelligence to associate data with environment or to control systems by feedback Contact --> contact@touchsensity.com
Show all 32 investments ↓
Experience · 46 entries
All (46)
Investments (40)
Founder (1)
Board (14)
2025
Venture Partner
Apr 2025
Aster is a Climate Tech VC with two decades of experience, specialized in hard-to-abate sectors. We invest in sectors including energy, logistics, mobility, manufacturing, building, chemicals, agriculture and more.
2024
VC Investor
Oct 2024
AXIOMA is an innovative and industrial biotech that contributes to the improvement of agricultural practices. For 10 years, our R&D team has been designing and approving biostimulation and biocontrol products which are then manufactured in our factories in Brive la Gaillarde. These products are then distributed under white label throughout the world by leading agricultural distribution partners. These innovations are made up of blends of active ingredients derived from plant extractions which, once combined, allow agricultural crops to better resist the effects of climate change, such as droughts or sudden variations in temperature. These so-called abiotic stresses are responsible for more than 50% of yield and/or crop quality losses. AXIOMA is therefore a technological ally that helps farmers to withstand these climatic and economic pressures, supports them in the evolution of farming practices, while responding favorably to societal expectations. AXIOMA est une biotech innovante et industrielle qui contribue à l’amélioration des pratiques agricoles. Depuis 10 ans, notre équipe de R&D conçoit et homologue des produits de biostimulation et de biocontrôle qui sont ensuite fabriqués dans nos usines de Brive la gaillarde. Ces produits sont par la suite distribués sous marque blanche à travers le monde par des partenaires leaders de la distribution agricole. Ces innovations sont composées d’assemblages d’actifs issus d’extractions végétales qui, une fois combinées, permettent aux cultures agricoles de mieux résister aux effets du changement climatique, comme les sécheresses ou les variations brutales de températures. Ces stress dits abiotiques sont responsables de plus de 50% des pertes de rendement et/ou de qualité des récoltes. AXIOMA est donc un allié technologique qui aide les agriculteurs à supporter ces pressions climatiques et économiques, les accompagne dans lévolution des pratiques culturales, tout en répondant favorablement aux attentes sociétales.
Board Member
Apr 2024
Nova Carbons mission is to democratize the use of carbon fiber by developing a range of high performance semi-finished products made from carbon fiber waste. Nova Carbons disruptive approach is based on Long Fiber Realignment, a technology patented by the University of Bordeaux that maintains the high performance of carbon fiber. Our semi-finished products are designed for the composites industry.
2023
Board Member
Nov 2023
RebrAIn offers a precise targeting technology for Deep Brain Stimulation (DBS). This is achieved through an algorithm based on Artificial Intelligence and a collaborative health data registry. With this innovative technology, developed to effectively identify the areas of the brain to be treated, ReBrain simplifies and standardizes DBS by reducing the risks and making it less traumatic, thus allowing more patients worldwide to be treated.
early stageMedical Device
Board Member
Nov 2023
SOTIMECO was born in 2017, from a meeting of minds eager to combine innovation with utility. Since then, our team has continued to grow, as have our ideas. Our main mission? To transform the metal additive manufacturing industry by making innovation not only accessible but also beneficial for everyone.
Show all 46 entries ↓
Investment activity
2021–2024 · 40 investments
2021102022820232020242
Recent (last 2 years)Earlier